Text Resize

-A +A

Research

What's on at Eureka Report and model portfolio updates

James Kirby

Alan's back next week - and we dissect our stocks' results.

Vita leverages Telstra, AMA sparks growth

Simon Dumaresq

Vita Group has delivered on every promise since we picked them, while crash repairer AMA is using acquisitions for further reach.

Saying goodbye to Specialty Fashion

Mitchell Sneddon

With better retail opportunities available in this market, we’re not waiting around to see a bounce back.

Our growth stories: Tox Free and Empired

Simon Dumaresq

There’s potential upside at Empired, while the waste management company has delivered an impressive performance against the mining slowdown.

Tatts’ High Court loss: Shareholders shouldn’t worry

James Samson

Despite an unsuccessful legal bid, there’s stability at the gaming operator.

Whole world in Henderson Group’s hands

Stocks In Value

The asset manager has enormous global product diversity and the ability to grow – we think it's fairly priced.

Wealth

A welcome rally does not a rebound make

Tim Treadgold

Hold on – those who wait out the bumps will find opportunities in resources.

How Fortescue outsmarted BHP and Rio

Tim Treadgold

A new deal could win both Fortescue and Vale a bigger share of the Chinese market – but does China want more iron ore?

Fund managers find new friends in volatile times

Emma Koehn

Managed funds are suddenly back in investors' good books - here's why.

Fact check: Have SMSFs peaked?

Bruce Brammall

A major fund is claiming customers are giving up on DIY funds and transferring their super to industry funds – but are we really seeing a slowdown?

Behind the Wall Street bounce

Randall W Forsyth

Stocks recover from the lows seen not too long ago, aided by crude oil’s comeback — and despite rancorous politics.

Collected Wisdom

Mitchell Sneddon

This week we look at BHP, Medibank, Nib, Orora and Regis Healthcare.